Abstract: Cardiac resynchronization therapy (CRT) is an established nonpharmacological treatment for patients with heart failure (HF), reduced left ventricular (LV) ejection fraction, and a wide QRS complex. Although the therapy was developed 30 years ago and approved by the Food and Drug Administration in 2001, attempts to improve it have never stopped. Such improvements have been facilitated by combining knowledge from bench (basic science), bits (computer modeling), and bedside (clinical studies); these issues are addressed in the present review. Improvements include better patient selection, positioning of the LV lead, pacing from multiple sites, and optimization of atrioventricular and ventriculo−ventricular intervals. Overall, patterns of electrocardiographic and echocardiographic (strain) signals appear to be more useful for patient selection than timing intervals (QRS duration, time-to-peak shortening). Quadripolar leads have significantly improved CRT outcome due to increased electrical and mechanical lead performance (avoiding phrenic nerve stimulation and improving lead stability), but also thanks to the flexibility offered by the novel leads to avoid in-scar pacing. The benefit of multiple site stimulation over optimal conventional biventricular pacing seems small and is awaiting evidence from large trials. There is rapidly growing interest in merging imaging information to guide positioning of the LV lead in late activated regions without scar and in LV lead positions other than the epicardial coronary veins (LV endocardium, His bundle, LV septum). All these developments look promising but await further clinical validation. Finally, computer modeling is rapidly becoming important in understanding the substrate for CRT, in improving and assisting patient selection, as well as in guiding therapy planning. 
It has been revolutionary for patients with advanced HF whose only previous option was cardiac transplantation, and it is now a realistic option for patients with mild HF (3,4). CRT remains the only therapy for HF that simultaneously improves cardiac function and functional capacity, reduces hospitalization, and prolongs survival ( Figure 1) . The large range of benefits among patients, spanning from complete normalization of ventricular volume and ejection fraction to a complete lack of benefit, has triggered significant research activities to de-convolute the biological and mechanistic aspects for CRT inefficacy, some of which are discussed in the present review and are illustrated in Figure 2 .
From the beginning, research in the field of CRT has been characterized by a bedside-to-bench and back again approach, whereas during the last decade, computer models have provided rapidly increasing additional insights. Therefore, this review discusses the combination of "bench, bits, and bedside" (which we named "the 3B perspective") by considering that the combination of these 3 factors may bring the field forward.
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The 3B Perspective in CRT
PATHOBIOLOGY OF CRT
Dyssynchrony and its correction by CRT induces a wide range of changes beyond the direct electrical and mechanical effects, many of which are unique to the disease. The seminal work by the Baltimore group showed that dyssynchronous HF is characterized by maladaptive remodeling processes at all levels, ranging from the genome to the proteome, transcriptome, metabolome, and is visible at the cellular level, translating to the phenotype (9) . Altogether, these abnormalities have been referred as dyssynchronopathy (9) . In dyssynchronous HF, most of the defects are specific to early-or late-activated myocardial territories, including processes like hypertrophy and related expression of microRNAs (10) . CRT can correct most of these defects by mechanisms that are still not completely elucidated.
Although little information is available on the tissue changes in human dyssynchronous hearts, several clinical trials showed that patients with LBBB in the control arms had a worse prognosis than patients with otherwise similar degrees of HF but no LBBB (11) . In contrast, once treated by CRT, the LBBB patients had an improved outcome beyond that of other patients, supporting an idea that originated from animal experiments on extensive cellular and molecular recovery. Clinical data were limited to reductions in cavity dimensions and levels of circulating plasma markers of inflammation, such as apoptotic signaling of fibrosis. Some studies indicated that, upon turning CRT off after several months, intrinsic QRS duration was reduced (12) Measuring and interpreting the QRS complex from a standard 12-lead ECG is a lengthy and tedious process, especially if the patient has an underlying disease (e.g., previous myocardial infarction or myocardial hypertrophy), which may further alter the morphology and duration of QRS. Although the QRS delineation and duration are believed to be usually easier to be determined than notching and slurring, recent reports have indicated large interobserver and intraobserver variability in manual reading (13) , as well as limited accuracy and precision of automated measurements of QRS duration among ECGs (14) . The difference could exceed the level of 10 to 15 ms, which might be considered clinically significant for qualifying a patient for CRT or for providing a class of recommendation for CRT (14) .
Interestingly, there is limited literature on the correlation of a specific morphological marker associated with intraventricular conduction disturbance, LBBB, or right bundle branch block (RBBB) with clinical in vivo measurements of intracardiac activation times.
Also, the threshold of 120 ms that indicates an abnormal QRS duration was established based on a pattern recognition that compared dogs with humans, not on objective measurements in humans (15) .
Although most patients treated with CRT have a LBBB QRS morphology, since the introduction of CRT into clinical practice, a growing number of patients with RBBB QRS morphology or intraventricular conduction abnormalities have also been treated. A recent review reported that an average of 18% of all treated CRT patients had RBBB, with a variable proportion ranging from 5% to 26% (16) . Thus, these patients represent a sizeable subgroup in need of adjunct therapies on top of the best pharmacological therapy.
The available evidence indicates that straightforward 
The 3B Perspective in CRT application of CRT in patients with RBBB should be discouraged (16) . However, in vivo mapping data and in silico simulation indicates that there is a subset of patients with RBBB who may benefit from CRT; these patients are characterized by a QRS morphology on limb leads that resemble a LBBB and show delayed LV activation, particularly of the LV free wall (17) . Thus, an individualized treatment strategy in RBBB is of utmost importance and should be used based on the presence of LV and right ventricular (RV) dyssynchrony demonstrated either by advanced echocardiographic techniques (18) or by the surface ECG (17) .
Admittedly, the treatment options for these patients with RBBB, previously proposed by us, have been mechanistically developed (12) , and may require confirmation in larger prospective studies.
Therefore, due to all of the previously indicated limitations of surface ECG in precisely defining bundle branch block and reliable prediction of CRT response, other ECG-derived indexes may be worth considering. (A) Acute hemodynamic effect as reported by the PATH-CHF study (adapted from Auricchio A, et al. [5] ). (B) Reverse remodeling as described in REVERSE study (adapted from Linde C, et al. [6] ). (C) Reduction in hospitalization for heart failure as shown by MADIT-CRT (adapted from Moss A, et al. [7] ). (D) Reduction in mortality as reported by the RAFT trial (adapted from Tang et al., [8] ). CRT ¼ cardiac resynchronization therapy; CI ¼ confidence interval; ICD ¼ implantable cardioverter-defibrillator; LV dP/dtmax ¼ first derivative of left ventricular pressure;
LVESVi ¼ left ventricular end-systolic volume index.
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BEYOND CONVENTIONAL 12-LEAD ECG. Of all the characteristics of a LBBB-like conduction abnormality, delayed activation of the LV is likely crucial for a heart to be amenable to CRT (19) . This inferred abnormality is supported by studies that showed that a greater delay in time from onset of the QRS complex to local LV activation at the LV stimulation site (Q-LV) was associated with a greater likelihood of benefit from CRT (20) . The most accurate way to determine late LV activation is to directly measure it 
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The 3B Perspective in CRT could not be reached due to lack of an appropriate coronary vein. This resulted in the placement of a quadripolar LV lead adjacent to or in the scar. This observation strongly suggests that further improvement in alternative lead positioning is needed
(see Emerging Technologies for Resynchronizing the Heart). Multipoint CRT).
The 3B Perspective in CRT to 5% points) and stroke volume (by w5%) (48,49).
Small studies also showed a moderately better Patients with LBBB underwent an acute hemodynamic Auricchio and Prinzen
The 3B Perspective in CRT Finally, the fact that stimulating additional pacing electrodes reduces device battery longevity should be taken into consideration.
EMERGING TECHNOLOGIES FOR RESYNCHRONIZING THE HEART: ENDOCARDIAL PACING, TRANSSEPTAL PACING, AND HIS BUNDLE PACING
The common denominators for emerging technologies for resynchronizing the heart aim at creating activation patterns that are more physiological than transvenous CRT; they do not aim at positioning the lead in the latest activated region (Figure 4) .
LV endocardial pacing has been proposed and has been shown to be superior to conventional LV epicardial pacing in the CRT setting in computer simulations (54) and preclinical experiments (55, 56 .
Auricchio and Prinzen In these patients with sick sinus disease, LV septal pacing reduced electric dyssynchrony and preserved LV pump function compared with RV septal and RV apex pacing. Electric and mechanical lead properties of this prototype lead remained stable during 6-month follow-up. Notably, LV septal pacing may avoid deterioration of LV function due to long-term RV pacing in patients with bradycardia, but data from animal studies suggest that it might also be an alternative to BiV pacing (69) .
NOVEL PACING ALGORITHMS FOR AUTOMATIC SELECTION OF ATRIOVENTRICULAR AND VV DELAY
Since the early days of CRT, appropriate selection of AV delay and VV timing has been considered an Auricchio and Prinzen
The 3B Perspective in CRT These findings indicate that more attention to the change in mechanical contraction after CRT may further improve the benefit of CRT for patients.
COMPUTER MODEL-ASSISTED PATIENT SELECTION AND CRT APPLICATION
Computer models can contribute in several ways to improve clinical practice: better understanding of
The 3B Perspective in CRT mechanisms of disease and therapy; better interpretation of diagnostic measurements; and altogether better planning of the therapy in the individual patient by virtual delivery of therapy. Such models can also be used to improve the design of clinical trials.
Currently, there are even developments to create cohorts of virtual patients for performing clinical trials in silico (80) . The field of CRT is ideal for applying Auricchio and Prinzen
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The 3B Perspective in CRT computer models because conceptual integration of all electrophysiological, contractile, and circulatory properties of a patient are too complex for the human brain. However, these models may be appropriately handled by high-performing computers and sophisticated mathematical algorithms that are capable of delivering simulations in a clinical usable timing.
Computer models of the dyssynchronous heart range from relatively simple 2-dimensional models of cardiac contraction and hemodynamics (81) to highly advanced 3-dimensional models that contain fiber orientation, molecular properties of ion channels, myocardial contraction, and body surface ECG 
